{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T17:24:11Z","timestamp":1786469051012,"version":"build-2736575974"},"reference-count":73,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T00:00:00Z","timestamp":1452816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Metabolism is a chemical process used by cells to transform food-derived nutrients, such as proteins, carbohydrates and fats, into chemical and thermal energy. Whenever an alteration of this process occurs, the chemical balance within the cells is impaired and this can affect their growth and response to the environment, leading to the development of a metabolic disease. Metabolic syndrome, a cluster of several metabolic risk factors such as abdominal obesity, insulin resistance, high cholesterol and high blood pressure, and atherogenic dyslipidaemia, is increasingly common in modern society. Metabolic syndrome, as well as other diseases, such as diabetes, obesity, hyperlipidaemia and hypertension, are associated with abnormal lipid metabolism. Cellular lipids are the major component of cell membranes; they represent also a valuable source of energy and therefore play a crucial role for both cellular and physiological energy homeostasis. In this review, we will focus on the physiological and pathophysiological roles of the lysophospholipid mediator lysophosphatidylinositol (LPI) and its receptor G-protein coupled receptor 55 (GPR55) in metabolic diseases. LPI is a bioactive lipid generated by phospholipase A (PLA) family of lipases which is believed to play an important role in several diseases. Indeed LPI can affect various functions such as cell growth, differentiation and motility in a number of cell-types. Recently published data suggest that LPI plays an important role in different physiological and pathological contexts, including a role in metabolism and glucose homeostasis.<\/jats:p>","DOI":"10.3390\/metabo6010006","type":"journal-article","created":{"date-parts":[[2016,1,16]],"date-time":"2016-01-16T03:30:25Z","timestamp":1452915025000},"page":"6","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Lysophosphatidylinositol Signalling and Metabolic Diseases"],"prefix":"10.3390","volume":"6","author":[{"given":"Syamsul","family":"Arifin","sequence":"first","affiliation":[{"name":"Inositide Signalling Group, Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK"},{"name":"Department of Basic Medical Science for Nursing, Faculty of Nursing, IIUM, Bandar Indera Mahkota, Kuantan Pahang 25200, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9801-7235","authenticated-orcid":false,"given":"Marco","family":"Falasca","sequence":"additional","affiliation":[{"name":"Inositide Signalling Group, Centre for Cell Biology and Cutaneous Research, Blizard Institute, Queen Mary University of London, 4 Newark Street, London E1 2AT, UK"},{"name":"Metabolic Signalling Group, School of Biomedical Sciences, Curtin Health Innovation Research Institute Biosciences, Curtin University, Perth 6102, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,1,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The Metabolic Syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/en.2003-0288","article-title":"Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors","volume":"144","author":"Lee","year":"2003","journal-title":"Endocrinology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbalip.2012.07.015","article-title":"Lysophospholipids and Their Receptors in the Central Nervous System","volume":"1831","author":"Choi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tigyi, G. (2013). New Trends in Lysophospholipid Research. Biochim. Biophys. Acta.","DOI":"10.1016\/B978-0-12-378630-2.00465-5"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.yexcr.2014.11.020","article-title":"Lysophospholipid Receptors in Drug Discovery","volume":"333","author":"Kihara","year":"2015","journal-title":"Exp. Cell Res."},{"key":"ref_6","first-page":"694","article-title":"Lysophosphatidylinositol Signalling: New Wine from an Old Bottle","volume":"1821","author":"Falasca","year":"2012","journal-title":"Biochim. Biophys. Acta\u2014Mol. Cell Biol. Lipids"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/db11-0649","article-title":"The L-\u03b1-Lysophosphatidylinositol\/GPR55 System and its Potential Role in Human Obesity","volume":"61","author":"Whyte","year":"2012","journal-title":"Diabetes"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mce.2013.12.011","article-title":"Regulation of GPR55 in Rat White Adipose Tissue and Serum LPI by Nutritional Status, Gestation, Gender and Pituitary Factors","volume":"383","author":"Imbernon","year":"2014","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0006-291X(86)80556-3","article-title":"Lysophosphatidylinositol, but not Lysophosphatidic Acid Stimulates Insulin Release","volume":"138","author":"Metz","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0167-4889(88)90013-4","article-title":"Mobilization of Cellular Ca2+ by Lysophospholipids in Rat Islets of Langerhans","volume":"968","author":"Metz","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1432-1033.1994.tb18750.x","article-title":"Elevated Levels and Mitogenic Activity of Lysophosphatidylinositol in K-ras-transformed Epithelial Cells","volume":"221","author":"Falasca","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"ref_12","first-page":"2113","article-title":"Signalling Pathways Involved in the Mitogenic Action of Lysophosphatidylinositol","volume":"10","author":"Falasca","year":"1995","journal-title":"Oncogene"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1038\/sj.onc.1201758","article-title":"Release of the Mitogen Lysophosphatidylinositol from H-Ras-transformed Fibroblasts; A Possible Mechanism of Autocrine Control of Cell Proliferation","volume":"16","author":"Falasca","year":"1998","journal-title":"Oncogene"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/me.2011-1197","article-title":"Minireview: Recent Developments in the Physiology and Pathology of the Lysophosphatidylinositol-sensitive Receptor GPR55","volume":"25","author":"Henstridge","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.bbrc.2007.08.078","article-title":"Identification of GPR55 as a Lysophosphatidylinositol Receptor","volume":"362","author":"Oka","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.tips.2011.01.005","article-title":"L-\u03b1-lysophosphatidylinositol Meets GPR55: A Deadly Relationship","volume":"32","author":"Ross","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/JOE-11-0166","article-title":"A Role for the Putative Cannabinoid Receptor GPR55 in the Islets of Langerhans","volume":"211","author":"Rafacho","year":"2011","journal-title":"J. Endocrinol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00702-009-0355-1","article-title":"Differential Effects of Lysophospholipids on Exocytosis in Rat PC12 Cells","volume":"117","author":"Ma","year":"2010","journal-title":"J. Neural Transm."},{"key":"ref_19","first-page":"245","article-title":"The GPR55 Agonist Lysophosphatidylinositol Directly Activates Intermediate-conductance Ca2+-activated K+ Channels","volume":"262","author":"Bondarenko","year":"2011","journal-title":"Cardiovascular Phys."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00232-003-0616-0","article-title":"Modulation of Native TREK-1 and Kv1.4 K+ Channels by Polyunsaturated Fatty Acids and Lysophospholipids","volume":"195","author":"Danthi","year":"2003","journal-title":"J. Membr. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.bbamcr.2009.01.003","article-title":"Lysophospholipids Stimulate Prostate Cancer Cell Migration via TRPV2 Channel Activation","volume":"1793","author":"Monet","year":"2009","journal-title":"Biochim. Biophys. Acta\u2014Mol. Cell Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and Cloning of Three Novel Human G protein-coupled receptor Genes GPR52, Psi GPR53 and GPR55: GPR55 is Extensively Expressed in Human Brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Mol. Brain Res."},{"key":"ref_23","unstructured":"Brown, A., and Wise, A. (2003). Identification of Modulators of GPR55 Activity. (10\/275,200), U.S. Patent."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The Orphan Receptor GPR55 is a Novel Cannabinoid Receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/onc.2010.417","article-title":"The Putative Cannabinoid Receptor GPR55 Defines a Novel Autocrine Loop in Cancer Cell Proliferation","volume":"30","author":"Maffucci","year":"2011","journal-title":"Oncogene"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/onc.2010.402","article-title":"The Orphan G Protein-coupled Receptor GPR55 Promotes Cancer Cell Proliferation via ERK","volume":"30","author":"Andradas","year":"2011","journal-title":"Oncogene"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1476-5381.2010.00743.x","article-title":"A Role for L-alpha-lysophosphatidylinositol and GPR55 in the Modulation of Migration, Orientation and Polarization of Human Breast Cancer Cells","volume":"160","author":"Ford","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_28","unstructured":"Gomez, E.P., Andradas, C., Flores, J., Quantanilla, M., Pamamio, J., Guzman, M., and Sanchez, C. (2012). The Orphan Receptor GPR55 Drives Skin Carcinogenesis and is Upregulated in Human Squamous Cell Carcinomas. Oncogene, 1\u20139."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1096\/fj.08-108670","article-title":"The GPR55 Ligand L-alpha-Lysophosphatidylinositol Promotes RhoA-dependent Ca2+ Signaling and NFAT Activation","volume":"23","author":"Henstridge","year":"2009","journal-title":"FASEB J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1073\/pnas.0711278105","article-title":"GPR55 is a Cannabinoid Receptor that Increases Intracellular Calcium and Inhibits M Current","volume":"105","author":"Lauckner","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/jb\/mvn136","article-title":"2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55","volume":"145","author":"Oka","year":"2009","journal-title":"J. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1242\/jcs.020958","article-title":"Integrin Clustering Enables Anandamide-induced Ca2+ Signaling in Endothelial Cells via GPR55 by Protection Against CB1-receptor-Triggered Repression","volume":"121","author":"Zoratti","year":"2008","journal-title":"J. Cell Sci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1111\/bph.12678","article-title":"Lysophospholipid Receptor Nomenclature Review: IUPHAR Review 8","volume":"171","author":"Kihara","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1124\/pr.110.003004","article-title":"International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB 1 and CB 2","volume":"62","author":"Pertwee","year":"2010","journal-title":"Pharmacol. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0024284","article-title":"Lysophosphatidylinositol Causes Neurite Retraction via GPR55, G13 and RhoA in PC12 Cells","volume":"6","author":"Obara","year":"2011","journal-title":"PLoS ONE"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.prostaglandins.2013.05.004","article-title":"The Actions and Metabolism of Lysophosphatidylinositol, an Endogenous Agonist for GPR55","volume":"107","author":"Yamashita","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1021\/bi200010k","article-title":"Identification of the GPR55 Agonist Binding Site Using a Novel Set of High-Potency GPR55 Selective Ligands","volume":"50","author":"Kotsikorou","year":"2011","journal-title":"Biochemistry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1476-5381.2009.00625.x","article-title":"GPR55 Ligands Promote Receptor Coupling to Multiple Signalling Pathways","volume":"160","author":"Henstridge","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1517\/17460441.2015.1058775","article-title":"Approaches of Targeting Rho GTPases in Cancer Drug Discovery","volume":"10","author":"Lin","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/bph.12356","article-title":"Evaluation of the Insulin Releasing and antihyperglycaemic Activities of GPR55 Lipid Agonists Using Clonal Beta-cells, Isolated Pancreatic Islets and Mice","volume":"170","author":"McKillop","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"AlSuleimani, Y.M., and Hiley, C.R. (2015). The GPR55 Agonist Lysophosphatidylinositol Mediates Vasorelaxation of the Rat Mesenteric Resistance Artery and Induces Calcium Release in Rat Mesenteric Artery Endothelial Cells. Br. J. Pharmacol.","DOI":"10.1111\/bph.13107"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/sj.bjp.0707419","article-title":"The Novel Endocannabinoid Receptor GPR55 is Activated by Atypical Cannabinoids but Does Not Mediate Their Vasodilator Effects","volume":"152","author":"Johns","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1124\/jpet.113.204180","article-title":"A Selective Antagonist Reveals a Potential Role of G protein-coupled Receptor 55 in Platelet and Endothelial Cell Function","volume":"346","author":"Kargl","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.coph.2012.09.009","article-title":"A Potential Role for GPR55 in Gastrointestinal Functions","volume":"12","author":"Schicho","year":"2012","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Stan\u010di\u0107, A., Jandl, K., Hasen\u00f6hrl, C., Reichmann, F., Marsche, G., Schuligoi, R., Heinemann, A., Storr, M., and Schicho, R. (2015). The GPR55 Antagonist CID16020046 Protects Against Intestinal Inflammation. Neurogastroenterol. Motil.","DOI":"10.1111\/nmo.12639"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3945\/jn.115.210104","article-title":"Postprandial Plasma Phospholipids in Men Are Influenced by the Source of Dietary Fat","volume":"145","author":"Meikle","year":"2015","journal-title":"J. Nutr."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2004.11.120","article-title":"Lysophosphatidylcholine Enhances Glucose-dependent Insulin Secretion via an Orphan G-protein-coupled Receptor","volume":"326","author":"Soga","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.tips.2012.03.014","article-title":"GPR119 as a Fat Sensor","volume":"33","author":"Hansen","year":"2012","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.febslet.2009.05.028","article-title":"Differential Changes in GPR55 During Microglial Cell Activation","volume":"583","author":"Pietr","year":"2009","journal-title":"FEBS Lett."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/mol.115.099333","article-title":"The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray","volume":"88","author":"Deliu","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000339076","article-title":"Evidence for the Putative Cannabinoid Receptor (GPR55)-mediated Inhibitory Effects on Intestinal Contractility in Mice","volume":"90","author":"Ross","year":"2012","journal-title":"Pharmacology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1113\/jphysiol.2010.204594","article-title":"Impaired Intestinal Afferent Nerve Satiety Signalling and Vagal Afferent Excitability in Diet Induced Obesity in the Mouse","volume":"589","author":"Daly","year":"2011","journal-title":"J. Physiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/nrendo.2012.189","article-title":"The Vagus Nerve and the Inflammatory Reflex-linking Immunity and Metabolism","volume":"8","author":"Pavlov","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","article-title":"The Putative Cannabinoid Receptor GPR55 Plays a Role in Mechanical Hyperalgesia Associated with Inflammatory and Neuropathic Pain","volume":"139","author":"Staton","year":"2008","journal-title":"Pain"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0304-3959(90)91074-S","article-title":"A Novel Behavioral Model of Neuropathic Pain Disorders Produced in Rats by Partial Sciatic Nerve Injury","volume":"43","author":"Seltzer","year":"1990","journal-title":"Pain"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.4049\/jimmunol.164.11.5998","article-title":"Differential Expression and Regulation of Toll-like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells","volume":"164","author":"Muzio","year":"2000","journal-title":"J. Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"16511","DOI":"10.1073\/pnas.0902743106","article-title":"The Putative Cannabinoid Receptor GPR55 Affects Osteoclast Function in Vitro and Bone Mass in Vivo","volume":"106","author":"Whyte","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.bcp.2013.11.016","article-title":"Increase of Mesenchymal Stem Cell Migration by Cannabidiol via Activation of p42\/44 MAPK","volume":"87","author":"Schmuhl","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/syn.20821","article-title":"Functional Polymorphism in the GPR55 Gene is Associated with Anorexia Nervosa","volume":"65","author":"Ishiguro","year":"2011","journal-title":"Synapse"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1463-1326.2011.01515.x","article-title":"The Atypical Cannabinoid O-1602 Stimulates Food Intake and Adiposity in Rats","volume":"14","author":"Pulido","year":"2012","journal-title":"Diabetes. Obes. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Meadows, A., Jh, L., Cs, W., Wei, Q., Pradhan, G., Yafi, M., and Hc, L. (2015). Deletion of G-protein Coupled Receptor 55 Promotes Obesity by Reducing Physical Activity. Int J. Obes.","DOI":"10.1038\/ijo.2015.209"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neuropharm.2013.03.029","article-title":"A Role for O-1602 and G protein-Coupled Receptor GPR55 in the Control of Colonic Motility in Mice","volume":"71","author":"Li","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_63","first-page":"332","article-title":"Role of Orphan G protein-coupled Receptor 55 in Diabetic Gastroparesis in Mice","volume":"66","author":"Lin","year":"2014","journal-title":"Sheng Li Xue Bao"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/1440-1681.12355","article-title":"Elevated Cannabinoid Receptor 1 and G protein-coupled Receptor 55 Expression in Proximal Tubule Cells and Whole Kidney Exposed to Diabetic Conditions","volume":"42","author":"Jenkin","year":"2015","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Overgaard, A.J., Weir, J.M., de Souza, D.P., Tull, D., Haase, C., Meikle, P.J., and Pociot, F. (2015). Lipidomic and Metabolomic Characterization of a Genetically Modified Mouse Model of the Early Stages of Human Type 1 Diabetes Pathogenesis. Metabolomics.","DOI":"10.1007\/s11306-015-0889-1"},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Walsh, S.K., Hector, E.E., Andr\u00e9asson, A.-C., J\u00f6nsson-Rylander, A.-C., and Wainwright, C.L. (2014). GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-mediated Inotropic Responses. PLoS ONE.","DOI":"10.1371\/journal.pone.0108999"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11010-015-2505-0","article-title":"Phospholipid Alterations in the Brain and Heart in a Rat Model of Asphyxia-Induced Cardiac Arrest and Cardiopulmonary Bypass Resuscitation","volume":"408","author":"Kim","year":"2015","journal-title":"Mol. Cell. Biochem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1161\/ATVBAHA.114.304748","article-title":"Possible Involvement of Minor Lysophospholipids in the Increase in Plasma Lysophosphatidic Acid in Acute Coronary Syndrome","volume":"35","author":"Kurano","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lanuti, M., Talamonti, E., Maccarrone, M., and Chiurchi\u00f9, V. (2015). Activation of GPR55 Receptors Exacerbates OxLDL-induced Lipid Accumulation and Inflammatory Responses, While Reducing Cholesterol Efflux from Human Macrophages. PLoS ONE.","DOI":"10.1371\/journal.pone.0131850"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Falasca, M., and Ferro, R. (2015). Role of the Lysophosphatidylinositol\/GPR55 Axis in Cancer. Adv. Biol. Regul.","DOI":"10.1016\/j.jbior.2015.10.003"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1042\/BST20140151","article-title":"Lysophosphatidylinositol: A novel link between ABC transporters and G-protein-coupled receptors","volume":"42","author":"Ruban","year":"2014","journal-title":"Biochem. Soc. Trans."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Simcocks, A.C., O\u2019Keefe, L., Jenkin, K.A., Mathai, M.L., Hryciw, D.H., and McAinch, A.J. (2013). A Potential Role for GPR55 in the Regulation of Energy Homeostasis. Drug Discov. Today.","DOI":"10.1016\/j.drudis.2013.12.005"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pharmthera.2014.06.007","article-title":"GPR55: From Orphan to Metabolic Regulator?","volume":"145","author":"Liu","year":"2015","journal-title":"Pharmacol. Ther."}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/6\/1\/6\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:17:48Z","timestamp":1760210268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/6\/1\/6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,15]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,3]]}},"alternative-id":["metabo6010006"],"URL":"https:\/\/doi.org\/10.3390\/metabo6010006","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,15]]}}}